News

This study focused on a key challenge: in many bowel cancers, especially stromal-rich types (those with lots of supporting tissue, or stromal cells, around the tumor), immune therapies aren’t working as well as hoped. Researchers investigated how certain “support” cells within the tumor (called stromal cells) may be actively helping the cancer by suppressing the body’s immune system. Then they investigated how to turn the immune system back on again in these hard-to-treat can

A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI) Led by pioneering surgical oncologist Dr. Paul Sugarbaker, PSOGI is a collaboration of experts from around the world on the treatment of peritoneal cancer and is dedicated to improving treatment and survival of patients with peritoneal metastases . While PSOGI World News  is a quarterly publication primarily intended for healthcare professionals, t

When you hear “clinical trials,” you might think of the drug companies doing studies of new medicines. But did you know that federally funded trials—backed by government agencies—play a unique and absolutely critical role in cancer research? A recent study shows just how important they are for rare cancers, children, and complex treatment strategies.

The National Cancer Institute (NCI)  — the nation’s leading cancer research agency — has a new director. Dr. Anthony Letai officially...

Carlos A Munoz-Zuluaga ,  Mary Caitlin King ,  Panayotis Ledakis ,  Vadim Gushchin ,  Michelle Sittig ,  Carol Nieroda ,  Katherine Zambrano-Vera ,  Armando Sardi Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin . European Journal of Surgical Oncology. 2019 Sep;45(9):1598-1606. https://pubmed.ncbi.nlm.nih.gov/31109821/ Summary: Researche

Ekaterina Baron, Armando Sardi, Mary Caitlin King, Andrei Nikiforchin, Felipe Lopez-Ramirez, Carol Nieroda, Vadim Gushchin, Panayotis...

Serkan Yaşar MD , Feride Yılmaz MD , Güngör Utkan MD , Efnan Algın MD , Doğan Bayram, MD , Selim Tamam MD , Ömür Berna Çakmak Öksüzoğlu...

Mary Kathryn Abel, MD, MAS ; Varvara Mazina, MD ; Amy J. Bregar, MD; et al. JAMA Network Open; Published Online: July 25, 2025;...

Leah E. Hendrick, MD , Seth Felder, MD , Iman Imanirad, MD , and Sean P. Dineen, MD, MHPE JCO Oncology Practice (Oct 2024). Volume 21,...

OVHIPEC-1 confirms that for women with advanced ovarian cancer, combining HIPEC with cytoreductive surgery can provide a meaningful, long-term survival benefit while maintaining quality of life.

Marco Tonello MD, PhD , Carola Cenzi MS, PhD , Elisa Pizzolato MD , Manuela Martini RN , Pierluigi Pilati MD & Antonio Sommariva MD  ...

A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI) Led by...

Sven Mahner, Florian Heitz, Sahar Salehi, Alexander Reuss, Frederic Guyon, Andreas du Bois, Philipp Harter, Christina Fotopoulou, Denis...

Real-world social determinants of health (SDOH) and outcomes of early-onset colorectal cancer (EO-CRC): An analysis of a large,...

Researchers used National Cancer Institute data to compare appendix cancer rates across generations. They found that people born in the 1980s were three to four times more likely to be diagnosed with this cancer than those born in the 1940s.

Maheswari Senthil, Farshid Dayyani BMC Cancer ​This research article about the STOPGAP trial explores a new treatment approach for...

A quarterly newsletter with the latest news, views and announcements from Peritoneal Surface Oncology Group International (PSOGI) Led by...

Edward A. Levine MD, Heidy Cos MD, Konstantinos I. Votanopoulos MD, PhD, Perry Shen MD, Greg Russell MS, Paul Mansfield MD, Keith...

Sergei Iugai MD, Mary Caitlin King BS, Vladislav Kovalik MD MPSH, Luis Felipe Falla-Zuniga MD, Kseniia Uzhegova MD, Abeerah Wasti BS,...